Skip to Main Content
Pharmacy Technician's Letter Canada
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • Natural Medicines Resources
  • CE & Training
    • CE Organizer
    • Available Courses
    • Live CE Calendar
    • Print Statements
    • Licenses
    • Additional Requirements
    • Exemptions
  • New Drugs
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

New! PTU Elite: Point-of-Care Testing, a comprehensive training program that teaches pharmacy technicians to safely perform CLIA-waived tests.

  1. Home
  2. Browse
  3. Cardiology
  4. Dyslipidemia
  5. Treatment

Treatment

  • Angina (13)
  • Antithrombotics (172)
  • Arrhythmias (96)
  • Blood Pressure (29)
  • Cardiovascular Disease and Depression (5)
  • Cholesterol (67)
  • Dyslipidemia (167)
    • Cholesterol Testing / Screening (25)
    • Guidelines (8)
    • Other Uses for Lipid Drugs (3)
    • Treatment (148)
      • Bile Acid Sequestrants (14)
      • Combination Therapies (36)
      • Ezetimibe (25)
      • Fibric Acid Derivatives (25)
      • Natural Medicines/Supplements (26)
      • Niacin (23)
      • PCSK9 Inhibitors (20)
      • Statins (116)
      • Treatment of Pediatric Dyslipidemia (5)
  • Endocarditis (15)
  • Heart Disease (52)
  • Heart Failure (118)
  • Hypertension (177)
  • Hypotension (12)
  • Ischemic Heart Disease/Acute Coronary Syndromes (226)
  • Myocardial Infarction (30)
  • Peripheral Vascular Disease (5)
  • Raynaud's (2)
  • Resources (551)
  • Stroke (81)
106 - 120 of 148 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Guideline: Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: Summary Reports (2011) January 2012
Commentary: Treatment of Hyperlipidemia in Children and Adolescents January 2012
Commentary: Diabetes Meds and Cardiovascular Risk November 2011
Commentary: New Restrictions, Contraindications, and Dose Limitations for Zocor (Simvastatin) September 2011
Commentary: Flaxseed: Is It As Beneficial As Fish Oil? December 2010
Commentary: Omega-6 and Omega-9 Fatty Acids December 2010
Commentary: Krill Oil: A Substitute for Fish Oil? August 2010
Commentary: Increased Risk of Muscle Injury with High-Dose Zocor (Simvastatin) April 2010
Commentary: Ezetimibe vs. Niacin for Atherosclerosis: The ARBITER 6-HALTS Study January 2010
Other: Niacin Titration Schedule January 2010
Commentary: Generic Drug Approval Process: An Update October 2009
Chart: Histamine H2 Blocker Oral Dose Comparison August 2009
Chart: Sulfonylurea Dose Comparison August 2009
Chart: Proton Pump Inhibitor Dose Comparison August 2009
Commentary: Nuvigil (Armodafinil) July 2009
  • « Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Careers
  • News and Resources
  • Products
  • Individual Solutions
  • Enterprise Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved